MEI Pharma Newsroom

Laidlaw Cuts MEI Pharma to Hold Over Shutdown Concerns

Seeking AlphaJul 24 04:19

MEI Pharma Analyst Ratings

BenzingaJul 23 18:46

Laidlaw Initiates MEI Pharma(MEIP.US) With Hold Rating

Futu NewsJul 23 17:32

Brookline Capital Downgrades MEI Pharma(MEIP.US) to Hold Rating

Futu NewsJul 23 00:31

Stifel Nicolaus Reaffirms Their Hold Rating on MEI Pharma (MEIP)

TipRanksMay 16 10:15

Stifel: Maintaining the MEI Pharma (MEIP.US) rating, adjusted from holding to holding rating, and adjusting the target price from $7.00 to $7.00.

Zhitong FinanceApr 12 23:50

MEI Pharma Analyst Ratings

BenzingaApr 12 23:50

Stifel Maintains Hold on MEI Pharma, Maintains $7 Price Target

BenzingaApr 12 23:50

MEI Pharma Analyst Ratings

BenzingaFeb 14 21:59

Stifel Nicolaus Reaffirms Their Hold Rating on MEI Pharma (MEIP)

TipRanksNov 15, 2023 10:05

Stifel Maintains Hold on MEI Pharma, Lowers Price Target to $9

BenzingaSep 27, 2023 20:29

MEI Pharma Analyst Ratings

BenzingaSep 27, 2023 20:28

Stifel Nicolaus Sticks to Its Hold Rating for MEI Pharma (MEIP)

TipRanksJun 7, 2023 10:07

Brookline Capital Maintains Buy on MEI Pharma, Announces $80 Price Target

BenzingaMay 24, 2023 00:14

Watching MEI Pharma; Hearing Brookline Capital Reiterates Buy Rating, $80 Price Target

BenzingaMay 23, 2023 23:47

Stifel Adjusts MEI Pharma's Price Target to $10 From $0.50, Keeps Hold Rating

MT NewswiresMay 12, 2023 22:20

BTIG Reaffirms Their Hold Rating on MEI Pharma (MEIP)

TipRanksFeb 14, 2023 19:00

HC Wainwright Adjusts Price Target on MEI Pharma to $2 From $5, Maintains Buy Rating

MT NewswiresFeb 14, 2023 11:30

Stifel Nicolaus Adjusts MEI Pharma Price Target to $0.50 From $2, Maintains Hold Rating

MT NewswiresFeb 14, 2023 11:25

MEI Pharma Analyst Ratings

Benzinga Analyst RatingsFeb 13, 2023 19:16